| Medicinal cannabis: history, pharmacology, and implications for the acute care setting MB Bridgeman, DT Abazia Pharmacy and therapeutics 42 (3), 180, 2017 | 738 | 2017 |
| Burnout syndrome among healthcare professionals PJ Bridgeman, MB Bridgeman, J Barone The Bulletin of the American Society of Hospital Pharmacists 75 (3), 147-152, 2018 | 669 | 2018 |
| Dipeptidyl peptidase-4 (DPP-4) inhibitors in the management of diabetes R Pathak, MB Bridgeman Pharmacy and Therapeutics 35 (9), 509, 2010 | 209 | 2010 |
| Exploring transitional care: evidence-based strategies for improving provider communication and reducing readmissions RP Mansukhani, MB Bridgeman, D Candelario, LJ Eckert Pharmacy and Therapeutics 40 (10), 690, 2015 | 127 | 2015 |
| Potassium-binding agents for the clinical management of hyperkalemia M Chaitman, D Dixit, MB Bridgeman Pharmacy and Therapeutics 41 (1), 43, 2016 | 86 | 2016 |
| Essential role of pharmacists in asthma care and management MB Bridgeman, LA Wilken Journal of Pharmacy Practice 34 (1), 149-162, 2021 | 75 | 2021 |
| Constipation in elderly patients with noncancer pain: focus on opioid-induced constipation S Chokhavatia, ES John, MB Bridgeman, D Dixit Drugs & aging 33, 557-574, 2016 | 68 | 2016 |
| Denosumab for the reduction of bone loss in postmenopausal osteoporosis: a review MB Bridgeman, R Pathak Clinical therapeutics 33 (11), 1547-1559, 2011 | 57 | 2011 |
| Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients D Dixit, MB Bridgeman, LB Andrews, N Narayanan, J Radbel, A Parikh, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (6 …, 2015 | 53 | 2015 |
| Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis MB Bridgeman Integrated Pharmacy Research and Practice, 109-119, 2017 | 51 | 2017 |
| Management of hepatic encephalopathy: a primer T Jawaro, A Yang, D Dixit, MB Bridgeman Annals of Pharmacotherapy 50 (7), 569-577, 2016 | 44 | 2016 |
| Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares R Soskind, DT Abazia, MB Bridgeman Expert opinion on pharmacotherapy 18 (11), 1115-1125, 2017 | 38 | 2017 |
| Presentation of scientific poster information: Lessons learned from evaluating the impact of content arrangement and use of infographics J Young, MB Bridgeman, ER Hermes-DeSantis Currents in Pharmacy Teaching and Learning 11 (2), 204-210, 2019 | 30 | 2019 |
| Myoclonus in renal failure: two cases of gabapentin toxicity KR Kaufman, A Parikh, L Chan, M Bridgeman, M Shah Epilepsy & behavior case reports 2, 8-10, 2014 | 30 | 2014 |
| Implementation of a pharmacist‐driven pain management consultation service for hospitalised adults with a history of substance abuse LB Andrews, MB Bridgeman, KS Dalal, D Abazia, C Lau, DF Goldsmith, ... International journal of clinical practice 67 (12), 1342-1349, 2013 | 27 | 2013 |
| Etelcalcetide (parsabiv) for secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis J Patel, MB Bridgeman Pharmacy and Therapeutics 43 (7), 396, 2018 | 26 | 2018 |
| Mirabegron: β3-Adrenergic Receptor Agonist for the Treatment of Overactive Bladder MB Bridgeman, NJ Friia, C Taft, M Shah Annals of Pharmacotherapy 47 (7-8), 1029-1038, 2013 | 25 | 2013 |
| Ulipristal acetate (Ella): a selective progesterone receptor modulator for emergency contraception A Kim, MB Bridgeman Pharmacy and therapeutics 36 (6), 325, 2011 | 24 | 2011 |
| Reefer madness or real medicine? A plea for incorporating medicinal cannabis in pharmacy curricula DT Abazia, MB Bridgeman Currents in Pharmacy Teaching and Learning 10 (9), 1165-1167, 2018 | 23 | 2018 |
| Mepolizumab (Nucala) for severe eosinophilic asthma MS Choy, D Dixit, MB Bridgeman Pharmacy and Therapeutics 41 (10), 619, 2016 | 21 | 2016 |
